Cited by 29Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection

Open access
Phan, Quynh T., Solis, Norma V., Cravener, Max V., Swidergall, Marc, Lin, Jianfeng, Huang, Manning Y., Liu, Hong, Singh, Shakti +4 more·2023·PLOS Pathogens

Abstract

Fungal invasion of the oral epithelium is central to the pathogenesis of oropharyngeal candidiasis (OPC). Candida albicans invades the oral epithelium by receptor-induced endocytosis but this process is incompletely understood. We found that C. albicans infection of oral epithelial cells induces c-Met to form a multi-protein complex with E-cadherin and the epidermal growth factor receptor (EGFR). E-cadherin is necessary for C. albicans to activate both c-Met and EGFR and to induce the endocytosis of C. albicans. Proteomics analysis revealed that c-Met interacts with C. albicans Hyr1, Als3 and Ssa1. Both Hyr1 and Als3 are required for C. albicans to stimulate c-Met and EGFR in oral epithelial cells in vitro and for full virulence during OPC in mice. Treating mice with small molecule inhibitors of c-Met and EGFR ameliorates OPC, demonstrating the potential therapeutic efficacy of blocking these host receptors for C. albicans.

AI snapshot

Written from the paper’s full text.

TL;DR

C. albicans hyphae activate c-Met on oral epithelial cells, and c-Met forms a multi-protein complex with EGFR and E-cadherin that mediates fungal endocytosis. Hyr1 and Als3 are required for maximal c-Met/EGFR activation and OPC virulence, and dual inhibition of c-Met and EGFR ameliorates OPC in mice.

Key findings

  • C. albicans hyphae induced c-Met autophosphorylation within 5 min and for at least 60 min; siRNA knockdown of c-Met or the c-Met inhibitor SGX523 reduced endocytosis by approximately 50%, while HGF enhanced endocytosis dose-dependently.
  • c-Met and EGFR were activated independently: gefitinib blocked EGFR phosphorylation without affecting c-Met, and SGX523 blocked c-Met phosphorylation without affecting EGFR; combined SGX523 plus gefitinib had an additive inhibitory effect on endocytosis.
  • E-cadherin knockdown reduced C. albicans-induced phosphorylation of both c-Met and EGFR; proximity ligation and co-immunoprecipitation showed infection increased a complex containing c-Met, EGFR, and E-cadherin.
  • Hyr1 was identified as a c-Met ligand; hyr1Δ/Δ and als3Δ/Δ mutants induced minimal c-Met/EGFR phosphorylation and were endocytosed poorly, and both Hyr1 and Als3 were required for maximal virulence in mouse OPC. In immunosuppressed mice, combined gefitinib and SGX523 significantly lowered oral fungal burden.

Methods

  • In vitro studies used OKF6/TERT-2 oral epithelial cells and NIH/3T3 fibroblasts, with C. albicans strains including SC5314 and mutants; assays included immunofluorescence, immunoblotting, siRNA knockdown, receptor inhibitors, proximity ligation, co-immunoprecipitation, far Western blotting, mass spectrometry, endocytosis/adherence assays, epithelial damage, cytokine measurement, and neutrophil killing.
  • Mouse OPC experiments used immunocompetent or cortisone acetate-immunosuppressed mice, oral infection with C. albicans strains, fungal burden measurements, histopathology, immunohistochemistry, phagocyte depletion with anti-GR-1 antibody, and Mrp8;Metfl/fl mice with neutrophil-specific c-Met deletion.
  • Statistical comparisons used two-tailed Student’s t tests or one-way ANOVA with Sidak’s multiple comparisons test; experiments were generally repeated at least three to five times, with triplicate samples where indicated.

Limitations

  • The paper does not include a dedicated limitations section.
  • Evident from the text: much of the mechanistic work uses the OKF6/TERT-2 oral epithelial cell line and NIH/3T3 fibroblasts, and the in vivo virulence and therapeutic inhibitor data come from mouse OPC models.
  • The authors state they were unable to determine whether Als3 and Hyr1 make additive contributions to epithelial cell invasion and adherence in vitro because the als3Δ/Δ mutant was endocytosed too poorly; the mechanism by which Hyr1 and Als3 mediate resistance to neutrophil killing is also stated to be unknown and independent of c-Met.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1011579

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

22 of 29 cited sources checked · 9 supported · 1 flagged · accuracy not yet measured

  • Findingcitation

    Hyr1 enables C. albicans to resist killing by neutrophils.

    “Previously, it was discovered that Hyr1 enables C. albicans to resist killing by neutrophils [24]. We verified this result with human neutrophils using hyr1Δ/Δ mutants constructed in both the SC5314 and SN250 strain backgrounds (Figs 8A and S5A).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [24] G Luo, 2010, Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target, J Infect Dis source
  • Premisecitation

    Hyr1 is required for maximal virulence in an immunosuppressed mouse model of OPC.

    “It has previously been found that Hyr1 also required for maximal virulence in an immunosuppressed mouse model of OPC [25].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [25] P Dwivedi, 2011, Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion., PLoS ONE. source
    • Rests on an assumption: The mouse model of oropharyngeal candidiasis is predictive of human oropharyngeal candidiasis.
  • Premisecitation

    Previously identified C. albicans invasins Als3 and Ssa1 mediate invasion of oral epithelial cells by interacting with E-cadherin and EGFR.

    “Previously, we identified two C. albicans invasins, Als3 and Ssa1 that mediate invasion of oral epithelial cells by interacting with E-cadherin and EGFR [16,17,19].”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [16] QT Phan, 2007, Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells, PLoS Biol source
    • cites [17] W Zhu, 2012, EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection, Proc Natl Acad Sci USA source
    • cites [19] JN Sun, 2010, Host cell invasion and virulence mediated by Candida albicans Ssa1., PLoS Pathog. source

      The Results sections on cadherin binding and Ssa1–Als3 interactions report that both invasins contribute to oral epithelial-cell invasion and link them to E-cadherin binding. The passages found do not identify EGFR as an interacting receptor (searched: EGFR and epidermal growth factor receptor), so that part of the claim is unsupported by this paper. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    Hyr1 contributes to virulence by enabling C. albicans to resist being killed by neutrophils.

    “Hyr1 has been found to contribute to virulence by enabling C. albicans to resist being killed by neutrophils [24].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [24] G Luo, 2010, Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target, J Infect Dis source
  • Findingown data

    siRNA knockdown of c-Met decreases endocytosis of C. albicans by approximately 50%.

    “Both siRNA knockdown of c-Met and blockade of c-Met kinase activity with the specific tyrosine kinase inhibitor SGX523 decreased the endocytosis of C. albicans by approximately 50% (Fig 1D and 1E).”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 18
  • May combine two claims. 32
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In most cancer cells, activation of c-Met requires EGFR and vice versa.

    “In most of these cancer cells, the activation of c-Met requires EGFR and vice versa.”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [33] KK Velpula, 2012, EGFR and c-Met cross talk in glioblastoma and its regulation by human cord blood stem cells, Transl Oncol source

      The Results section ('EGFR Inhibitors Annihilate c-Met Signaling Molecules'; page unavailable) reports that inhibiting either receptor reduced activation of the other in two glioblastoma cell lines. That supports reciprocal cross-talk, but not a strict requirement in most cancer cells. The Discussion (page unavailable) also describes a setting in which EGFR signaling functions independently of c-Met. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [34] KL Mueller, 2010, EGFR/Met association regulates EGFR TKI resistance in breast cancer, J Mol Signal source

      The Introduction reports a bidirectional interaction in SUM229 breast cancer cells: EGFR downregulation decreased Met phosphorylation, while EGFR phosphorylation was in part dependent on Met expression. The Discussion also describes other mechanisms of Met activation. These passages do not establish that activation of each receptor requires the other in most cancer cells; no page numbers are supplied. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [35] M Jo, 2000, Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells, J Biol Chem source

      The Discussion reports EGFR-dependent c-Met phosphorylation in several examined tumor cell lines, but says the cross-talk appears unidirectional: EGFR phosphorylates c-Met, not vice versa. The paper also does not extend this finding to most cancer cells. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Hyr1 is a hyphal-specific protein that inhibits C. albicans killing by neutrophils and contributes to virulence in mouse models of disseminated candidiasis and OPC.

    “This hyphal-specific protein has previously been found to inhibit C. albicans killing by neutrophils and contribute to virulence in mouse models of both disseminated candidiasis and OPC, but its host cell receptor was unknown [24,25].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [24] G Luo, 2010, Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target, J Infect Dis source

      The Results report that HYR1 expression reduced neutrophil-mediated killing in vitro and increased fungal burden in the liver and spleen of mice with hematogenously disseminated candidiasis. The paper describes HYR1 as hypha-associated, but the passages do not address a mouse model of OPC; that part of the claim is not supported by this source. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [25] P Dwivedi, 2011, Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion., PLoS ONE. source

      The Results and Discussion (page not supplied) describe Hyr1 as expressed during hyphal development and report resistance to neutrophil killing and reduced fungal burden for the hyr1/hyr1 mutant in a mouse oral infection model. Our copy does not establish Hyr1’s contribution to virulence in disseminated candidiasis or address whether its host-cell receptor was unknown. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    c-Met is known to function as a receptor for L. monocytogenes internalin B (InlB) and mediates endocytosis of this organism.

    “c-Met is also known to function as a receptor for L. monocytogenes internalin B (InlB) and mediates the endocytosis of this organism [31].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [31] Y Shen, 2000, InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase, Cell source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Als3 is required for both induced endocytosis and active penetration.

    “This result is in contrast to what has been found for Als3, which is required for both induced endocytosis and active penetration [29], and provides a likely explanation for why Hyr1 is dispensable for induction of epithelial cell damage.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [29] B Wachtler, 2012, Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process., PLoS ONE source

      The Results section, under “Relative Contributions of Active Penetration, Induced Endocytosis and C. Albicans Invasins to Epithelial Invasion,” concludes that Als3 plays major roles in both processes. But deletion reduced rather than eliminated invasion under either condition, and killed als3Δ hyphae still underwent some induced endocytosis. The paper supports Als3 as important to both routes, not strictly required for either. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In non-tumorgenic HaKat keratinocyte cell line, assembly of E-cadherin-containing adherens junctions activates EGFR in a ligand-independent manner.

    “By contrast, in the non-tumorgenic HaKat keratinocyte cell line, assembly of E-cadherin-containing adherens junctions activates EGFR in a ligand-independent manner [40].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [40] S Pece, 2000, Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation, J Biol Chem source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Hyr1 is a promising vaccine target for prevention of both C. albicans and Acinetobacter baumanii infections.

    “Previous studies by our group indicate that Hyr1 is a promising vaccine target for prevention of both C. albicans and Acinetobacter baumanii infections [42–44].”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [42] G Luo, 2011, Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis., PLoS ONE source

      The Results report that rHyr1p-N vaccination reduced fungal burden in mice challenged with C. albicans and other Candida species, supporting Hyr1 as a promising Candida vaccine target. Our copy does not report protection against Acinetobacter baumannii, so this source supports only the Candida part of the claim. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [43] P Uppuluri, 2018, The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection., PLoS Pathog. source
    • cites [44] S Singh, 2022, Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis., Front Immunol. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    CagA binds to and activates c-Met, stimulating epithelial cell motility and invasiveness, processes that are precursors to carcinogenesis.

    “CagA binds to and activates c-Met, stimulating epithelial cell motility and invasiveness, processes that are precursors to carcinogenesis [32].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [32] Y Churin, 2003, Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response, J Cell Biol source

      The Results and discussion (page unavailable) show that CagA interacts with phosphorylated c-Met and enhances the motogenic response of infected epithelial cells. They attribute c-Met activation to H. pylori infection, not specifically to CagA, and discuss increased invasiveness and cancer progression as possibilities rather than demonstrated effects or established precursors to carcinogenesis. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    H. pylori activates c-Met by injecting CagA into gastric epithelial cells via the type IV secretion system.

    “Helicobacter pylori activates c-Met by injecting cytotoxin-associated gene A (CagA) into gastric epithelial cells via the type IV secretion system.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [32] Y Churin, 2003, Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response, J Cell Biol source

      The Results and discussion report that H. pylori activates c-Met in gastric epithelial AGS cells and that the wild-type strain activates it more strongly than mutant strains. But c-Met was also activated without a functional type IV secretion system, so CagA translocation cannot fully explain the activation as the citing sentence implies. The paper links CagA translocation to an increased motogenic response. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    An additive or synergistic interaction between c-Met and EGFR has been found in multiple types of cancer cells, including breast cancer, hepatomas, and glioblastomas.

    “An additive or synergistic interaction between c-Met and EGFR has been found in multiple types of cancer cells, including breast cancer, hepatomas, and glioblastomas [33–35].”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [33] KK Velpula, 2012, EGFR and c-Met cross talk in glioblastoma and its regulation by human cord blood stem cells, Transl Oncol source

      The Discussion (page unavailable) reports positive EGFR–c-Met cross talk in glioma cells. The Introduction (page unavailable) describes their coexpression in breast cancer and functional interaction in SUM229 cells. Our copy does not establish an additive or synergistic interaction in hepatomas, so it does not support the full list of cancer types. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [34] KL Mueller, 2010, EGFR/Met association regulates EGFR TKI resistance in breast cancer, J Mol Signal source
    • cites [35] M Jo, 2000, Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells, J Biol Chem source

      The Discussion (page not provided) reports EGFR–c-Met cross-talk in human hepatoma cell lines and an epidermoid carcinoma cell line. It does not establish an additive or synergistic effect, and it does not report this interaction in breast cancer cells or glioblastomas. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Both c-Met and EGFR are known to form complexes with E-cadherin in cancer cells, and formation of such complexes is usually associated with inhibition of c-Met or EGFR phosphorylation.

    “While both c-Met and EGFR are known to form complexes with E-cadherin in cancer cells, the formation of such complexes is usually associated with inhibition of c-Met or EGFR phosphorylation [36–38].”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [36] S Hiscox, 1999, Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells, Biochem Biophys Res Commun source
    • cites [37] X Qian, 2004, E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases, Embo J source

      The Introduction reports that both c-Met and EGFR form complexes containing E-cadherin, and the EGFR/Neu results show reduced EGFR tyrosine phosphorylation under E-cadherin-mediated adhesion. However, the reported complexes and receptor-phosphorylation measurements are not in cancer cells. The tumor-cell results show attenuated EGF and HGF responses, not that c-Met/E-cadherin complex formation is associated with reduced c-Met phosphorylation; the Discussion describes the role of complex formation in regulation as a suggestion. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [38] AR Mateus, 2007, EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells, Hum Mol Genet source
  • May combine two claims.

    Findingown data

    The als3Δ/Δ mutant induces very little endocytosis, damage, or cytokine release.

    “By contrast, the als3Δ/Δ mutant induced very little endocytosis, damage, or cytokine release.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Both the als3Δ/Δ and hyr1Δ/Δ single mutants are endocytosed poorly by oral epithelial cells, with the invasion defect of the als3Δ/Δ mutant greater than that of the hyr1Δ/Δ mutant.

    “While both the als3Δ/Δ and hyr1Δ/Δ single mutants were endocytosed poorly by the oral epithelial cells, the invasion defect of the als3Δ/Δ mutant was greater than that of the hyr1Δ/Δ mutant (Fig 7D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    C. albicans interacts with c-Met on oral epithelial cells and this interaction is required for normal endocytosis of the fungus.

    “The data presented here indicate that C. albicans interacts with c-Met on oral epithelial cells and that this interaction is required for the normal endocytosis of the fungus.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The hyr1Δ/Δ mutant has normal adherence but is endocytosed poorly by oral epithelial cells.

    “Although the hyr1Δ/Δ mutant had normal adherence, it was endocytosed poorly by oral epithelial cells, (Figs 5K and S4A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The als3Δ/Δ single mutant and the hyr1Δ/Δ als3Δ/Δ double mutant cause virtually no epithelial cell damage.

    “Although the als3Δ/Δ single mutant and the hyr1Δ/Δ als3Δ/Δ double mutant caused virtually no epithelial cell damage, the hyr1Δ/Δ single mutant induced the same amount of damage as the wild-type strain (Fig 7E).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    There is low c-Met phosphorylation in oral epithelium of uninfected mice, and this phosphorylation increases after infection with wild-type C. albicans.

    “We found that there was low c-Met phosphorylation in the oral epithelium of uninfected mice and that this phosphorylation increased after infection with wild-type C. albicans (Fig 9A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Oral fungal burden of mice treated with either gefitinib or SGX523 is similar to untreated control mice, whereas oral fungal burden of mice treated with both is significantly lower.

    “We found that the oral fungal burden of mice treated with either gefitinib or SGX523 was similar to that of the untreated control mice, whereas the oral fungal burden of mice treated with both gefitinib and SGX523 was significantly lower (Fig 10E).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    siRNA knockdown of E-cadherin inhibited C. albicans-induced autophosphorylation of both c-Met and EGFR and inhibited endocytosis similarly to inhibition of c-Met and EGFR.

    “Importantly, siRNA knockdown of E-cadherin inhibited C. albicans-induced autophosphorylation of both receptors and inhibited the endocytosis of C. albicans similarly to inhibition of c-Met and EGFR.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    c-Met phosphorylation is reduced in mice infected with either als3Δ/Δ or hyr1Δ/Δ single mutants and almost undetectable in mice infected with hyr1Δ/Δ als3Δ/Δ double mutant.

    “The phosphorylation of c-Met was reduced in mice infected with either the als3Δ/Δ or hyr1Δ/Δ single mutants and was almost undetectable in mice infected with the hyr1Δ/Δ als3Δ/Δ double mutant.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    After 1 day of infection, oral fungal burden of mice infected with als3Δ/Δ or hyr1Δ/Δ mutants is similar to wild-type, whereas mice infected with hyr1Δ/Δ als3Δ/Δ double mutant have significantly lower fungal burden.

    “After 1 d of infection, the oral fungal burden of mice infected with either the als3Δ/Δ or hyr1Δ/Δ mutants was similar to that of mice infected with the wild-type strain, whereas mice infected with the hyr1Δ/Δ als3Δ/Δ double mutant had a significantly lower fungal burden (Fig 10A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Hyr1 also functions as an invasin that is required for C. albicans to activate both EGFR and c-Met in vitro and in the mouse model of OPC.

    “In the current work, we discovered that Hyr1 also functions as an invasin that is required for C. albicans to activate both EGFR and c-Met in vitro and in the mouse model of OPC.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning

    The hyr1Δ/Δ mutant stimulates less epithelial cell endocytosis but induces wild-type levels of damage and cytokine release.

    “The hyr1Δ/Δ mutant stimulated less epithelial cell endocytosis but induced wild-type levels of damage and cytokine release.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The combination of SGX523 and gefitinib inhibited endocytosis of C. albicans more than either inhibitor alone, indicating c-Met and EGFR/HER2 have additive effects on endocytosis.

    “A key finding was that the combination of SGX523 and gefitinib inhibited the endocytosis of C. albicans more than either inhibitor alone, indicating that c-Met and EGFR/HER2 have additive effects on the endocytosis of C. albicans.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Incubating cells with SGX523 and gefitinib in combination has an additive effect, inhibiting endocytosis significantly more than SGX523 alone.

    “Incubating the cells with SGX523 and gefitinib in combination had an additive effect, inhibiting endocytosis significantly more than SGX253 alone.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    C. albicans Als3 and Hyr1 cause c-Met, EGFR, and E-cadherin to form a multi-component complex that is essential for C. albicans-induced activation of c-Met and EGFR and subsequent epithelial cell endocytosis.

    “Collectively, these data support the model that C. albicans Als3 and Hyr1 cause c-Met, EGFR, and E-cadherin to form a multi-component complex that is essential for C. albicans-induced activation of c-Met and EGFR and the subsequent epithelial cell endocytosis of the fungus (Fig 6).”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    One potential explanation for these results is that although the hyr1Δ/Δ mutant has reduced receptor mediated endocytosis, it can still invade epithelial cells by active penetration, whereas the als3Δ/Δ mutant is defective in both modes of epithelial cell invasion.

    “One potential explanation for these results is that although the hyr1Δ/Δ mutant has reduced receptor mediated endocytosis, it can still invade epithelial cells by active penetration, whereas the als3Δ/Δ mutant is defective in both modes of epithelial cell invasion.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    E-cadherin is a central component of both the c-Met and EGFR endocytosis pathways.

    “The current data indicate that E-cadherin is a central component of both the c-Met and EGFR endocytosis pathways.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Hyr1 is required for induced endocytosis, but not active penetration.

    “Thus, Hyr1 is required for induced endocytosis, but not active penetration.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Als3 and/or Ssa1 are required for activation of both EGFR and c-Met.

    “Because Als3 and Ssa1 are surface expressed only on hyphae and are required for C. albicans to activate EGFR in oral epithelial cells [17], we tested a C. albicans als3Δ/Δ ssa1Δ/Δ mutant and found that it induced minimal phosphorylation of both EGFR and c-Met (Fig 5D–5F), suggesting that Als3 and/or Ssa1 are required for the activation of both receptors.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [17] W Zhu, 2012, EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection, Proc Natl Acad Sci USA source
  • May combine two claims.

    Interpretationown data

    Attenuated virulence of hyr1Δ/Δ als3Δ/Δ double mutant at day 2 is likely due to phagocyte-independent mechanisms, probably reduced epithelial cell invasion.

    “Thus, the attenuated virulence of the hyr1Δ/Δ als3Δ/Δ double mutant at this later time point is likely due to a phagocyte-independent mechanisms, probably reduced epithelial cell invasion.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    E-cadherin is a central component of the complex and is required for C. albicans to activate both c-Met and EGFR.

    “They also suggest that E-cadherin is a central component of this complex and is required for C. albicans to activate both c-Met and EGFR.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Both Hyr1 and Als3 reduce susceptibility of C. albicans to neutrophil killing, likely by functioning in the same pathway.

    “Thus, both Hyr1 and Als3 reduce the susceptibility of C. albicans to neutrophil killing, likely by functioning in the same pathway.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In gastric cancer cells, H. pylori CagA activates c-Met and causes it to form a complex with E-cadherin, which inhibits c-Met phosphorylation.

    “For example, in gastric cancer cells, H. pylori CagA activates c-Met and causes it to form a complex with E-cadherin, which inhibits c-Met phosphorylation [39].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [39] MJ Oliveira, 2009, CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype, J Infect Dis source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Neutrophils had >95% purity and >90% viability as determined by flow cytometry.

    “These neutrophils had > 95% purity and > 90% viability as determined by flow cytometry.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Each experiment was repeated at least four times.

    “Each experiment was repeated at least four times.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All strain genotypes were verified by PCR amplification of the desired marker from the target locus.

    “All strain genotypes were verified by PCR amplification of the desired marker from the target locus.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The extent of protein knockdown was determined by immunoblotting.

    “The extent of protein knockdown was determined by immunoblotting”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The experiments were repeated three times in triplicate.

    “The experiments were repeated three times in triplicate.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    After 2 days of infection, Hyr1 and Als3 contribute to virulence by a process independent of phagocytes, likely by enhancing epithelial cell invasion.

    “whereas after 2 days of infection, these surface proteins contribute to virulence by a process that is independent of phagocytes, likely by enhancing epithelial cell invasion.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The mouse model of oropharyngeal candidiasis is predictive of human oropharyngeal candidiasis.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All studies were performed using male Balb/c mice that were randomly assigned to the different experimental groups.

    “All studies were performed using male Balb/c mice that were randomly assigned to the different experimental groups.”
    Quote in the paperNot a substantial claim
40 of 40
  • The paper relies on this without support.

    The OKF6/TERT-2 oral epithelial cell line is a valid model of human oral epithelium for studying C. albicans invasion.

    “we infected the immortalized OKF6/TERT-2 oral epithelial cell line [21] with C. albicans hyphae”
  • The paper relies on this without support.

    The mouse model of OPC reflects human OPC pathogenesis.

    “To verify our in vitro data, we investigated the role of c-Met and Hyr1 in the pathogenesis of OPC in mice.”
  • The paper relies on this without support.

    SGX523 and gefitinib specifically inhibit c-Met and EGFR, respectively, without relevant off-target effects on C. albicans or host cells.

    “When the epithelial cells were treated with gefitinib, a specific inhibitor of EGFR kinase activity, and then infected with C. albicans, EGFR phosphorylation was reduced to basal levels but c-Met phosphorylation remained unchanged (Fig 2A and 2B).”
  • The paper relies on this without support.

    Phosphorylation of c-Met and EGFR is a valid proxy for their activation.

    “By immunoblotting of oral epithelial cell lysates with phosphospecific antibodies, we determined that C. albicans infection induced c-Met autophosphorylation that was detectable within 5 min and persisted for at least 60 min (Fig 1B and 1C).”
  • The paper relies on this without support.

    Hyr1's host cell receptor was unknown prior to this study.

    “This hyphal-specific protein has previously been found to inhibit C. albicans killing by neutrophils and contribute to virulence in mouse models of both disseminated candidiasis and OPC, but its host cell receptor was unknown [24,25].”
  • The paper relies on this without support.

    The mouse model of oropharyngeal candidiasis is predictive of human oropharyngeal candidiasis.

    “The results of the current studies indicate that Hyr1 is required for maximal virulence in during OPC in immunocompetent mice.”
  • The paper relies on this without support.

    In vitro neutrophil killing assays reflect phagocyte-mediated killing in vivo.

    “Although our data with c-Met deficient neutrophils indicate that c-Met is required for maximal killing of C. albicans, they also show that Hyr1 mediates resistance to neutrophil killing independently of c-Met.”
  • The paper relies on this without support.

    The antibodies used in immunofluorescence, proximity ligation, immunoprecipitation, and immunoblotting specifically detect their intended targets.

    “The phosphorylated proteins were detected by probing the membranes with an anti-phospho-c-Met antibody (Tyr1234/1235, #3077, Cell Signaling Technology) or an anti-phospho-EGFR antibody (Tyr1068, #2234, Cell Signaling Technology).”
  • The paper relies on this without support.

    The c-Met deficient neutrophils used are specifically deficient in c-Met and have no other relevant functional defects.

    “Although our data with c-Met deficient neutrophils indicate that c-Met is required for maximal killing of C. albicans”
9 of 9

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C. albicans Als3 adhesin binds to epithelial cell receptors E-cadherin, EGFR, Her2, and c-Met, and to macrophage receptor CR3.

    “the Als3 adhesin of C. albicans binds to receptors on epithelial cells, such as E-cadherin, EGFR, Her2, and c-Met, and receptors on macrophages, such as CR325–28.”

    From Adhesin Als4112 promotes Candida auris skin colonization through interactions with keratinocytes and extracellular matrix proteins (2025) · cites this paper as [27]

    The Introduction says c-Met interacts with Als3, and the Results (Fig. 6 model) place Als3 in an oral epithelial-cell complex containing E-cadherin, EGFR, HER2, and c-Met. That supports the epithelial-receptor association, but does not establish that Als3 binds each receptor directly. The paper does not address Als3 binding to macrophage CR3 (searched: CR3, macrophage receptor). (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Figure legend reverses the hyr1Δ/Δ mutant's susceptibility to neutrophil killing

    Minor

    The Fig 8 legend calls the mutant resistant to mouse neutrophil killing, whereas the results state that deleting HYR1 makes it more susceptible to that killing.

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Phan, Q. T., Solis, N. V., Cravener, M. V., Swidergall, M., Lin, J., Huang, M. Y., Liu, H., Singh, S., Ibrahim, A. S., Mazzone, M., Mitchell, A. P., & Filler, S. G.
Affiliations
  • University of California, Los Angeles (US)
  • University of Georgia (US)
  • University of California, San Francisco (US)
  • VIB-KU Leuven Center for Cancer Biology (BE)
Corresponding author
Filler, Scott G.
Venue
PLOS Pathogens
Published
2023-08-23
Volume
19
Issue
8
Pages
e1011579
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W4386086248
Cited by
29
References
55
Citations by year
2026: 7 · 2025: 14 · 2024: 7
FWCI
5.88
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Lirias (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Dental and Craniofacial Research (R01DE026600, R01DE031382)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Candida albicans, oropharyngeal candidiasis, epithelial cell invasion, c-Met, E-cadherin, epidermal growth factor receptor, fungal virulence, ALS3, Ssa1, host-pathogen interaction, c-Met inhibitor, EGFR inhibitors, oral epithelium
MeSH terms
Amyotrophic Lateral Sclerosis, Animals, Candida albicans, Candidiasis, Oral, Cell Membrane, Epithelial Cells, Cadherins, Mice, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-27.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-27.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review